Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Pantothenic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 known ✓ | P23219 | 1/20 | 0.61 |
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.61 |
| ▸ | VNN1 | O95497 | 13/20 | 0.53 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pantothenic Acid SCHEMBL7084077 | 1.00 | PTGS1 (0.61) | PTGS1KCNH2VNN1BBOX1MEN1 | |
| Pantothenic Acid SCHEMBL2455674 | 0.98 | PTGS1 (0.63) | PTGS1KCNH2VNN1BBOX1MEN1 | |
| Pantothenic Acid SCHEMBL30553124 | 0.98 | PTGS1 (0.63) | PTGS1KCNH2VNN1BBOX1MEN1 | |
| Pantothenic Acid SCHEMBL34428 | 0.98 | PTGS1 (0.63) | PTGS1KCNH2VNN1BBOX1MEN1 | |
| Pantothenic Acid SCHEMBL34427 | 0.98 | PTGS1 (0.63) | PTGS1KCNH2VNN1BBOX1MEN1 | |
| Pantothenic Acid SCHEMBL2455672 | 0.98 | PTGS1 (0.63) | PTGS1KCNH2VNN1BBOX1MEN1 | |
| Pantothenic Acid SCHEMBL29355079 | 0.98 | PTGS1 (0.63) | PTGS1KCNH2VNN1BBOX1MEN1 | |
| Pantothenic Acid SCHEMBL8044584 | 0.97 | PTGS1 (0.61) | PTGS1KCNH2VNN1BBOX1MEN1 | |
| Pantothenic Acid SCHEMBL11750098 | 0.97 | PTGS1 (0.61) | PTGS1KCNH2VNN1BBOX1MEN1 | |
| Pantothenic Acid SCHEMBL11750103 | 0.97 | PTGS1 (0.61) | PTGS1KCNH2VNN1BBOX1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104587473-B | A kind of preparation method to mesoporous apatite nano-medicament carrier of the liver cancer cells with reduction response and cell-targeting | 哈尔滨工业大学 | 2017-10-03 | — | — | CN | claimed |
| CN-104587488-B | A kind of preparation method of the mesoporous apatite nano-medicament carrier to liver cancer cells with pH responses and cell-targeting | 哈尔滨工业大学 | 2017-10-03 | — | — | CN | claimed |
| CN-104192817-B | Utilize the method for the high specific surface area and mesoporous hydroxyapatite nano particle of template synthesis | HARBIN INSTITUTE OF TECHNOLOGY (CN) | 2016-05-25 | — | — | CN | claimed |
| CN-104587473-A | Preparation method of mesoporous apatite nano-drug carrier with reduction responsiveness and cellular targeting property for hepatoma cell | HARBIN INST OF TECHNOLOGY | 2015-05-06 | — | — | CN | claimed |
| CN-104587488-A | Preparation method of mesoporous apatite nano-drug carrier with pH responsiveness and cellular targeting property for hepatoma cell | HARBIN INST OF TECHNOLOGY | 2015-05-06 | — | — | CN | claimed |
| CN-104548108-A | Preparation method of mesoporous apatite nano drug carrier with pH responsive core-shell structure | HARBIN INST OF TECHNOLOGY | 2015-04-29 | — | — | CN | claimed |
| CN-104192817-A | Method for preparing mesoporous hydroxyapatite nanometer particle with high specific surface area by virtue of template method | HARBIN INST OF TECHNOLOGY | 2014-12-10 | — | — | CN | claimed |
| CN-119073469-A | Application of stevia rebaudiana extract in feed for relieving liver injury of poultry | 江苏省家禽科学研究所 | 2024-12-06 | — | — | CN | disclosed |
| CN-118575898-A | Application of feed additive for improving intestinal flora disorder of poultry caused by salmonella in feed | 江苏省家禽科学研究所 | 2024-09-03 | — | — | CN | disclosed |
| CN-108640852-B | Method for adjusting bulk density and granularity of D-calcium pantothenate | 精晶药业股份有限公司 | 2020-12-25 | — | — | CN | disclosed |
| CN-104587488-B | A kind of preparation method of the mesoporous apatite nano-medicament carrier to liver cancer cells with pH responses and cell-targeting | 哈尔滨工业大学 | 2017-10-03 | — | — | CN | disclosed |
| CN-104587473-B | A kind of preparation method to mesoporous apatite nano-medicament carrier of the liver cancer cells with reduction response and cell-targeting | 哈尔滨工业大学 | 2017-10-03 | — | — | CN | disclosed |
| CN-104548108-B | A kind of preparation method of the mesoporous apatite nano-medicament carrier of pH responses core shell structure | 哈尔滨工业大学 | 2017-06-20 | — | — | CN | disclosed |
| CN-104548108-A | Preparation method of mesoporous apatite nano drug carrier with pH responsive core-shell structure | HARBIN INST OF TECHNOLOGY | 2015-04-29 | — | — | CN | disclosed |
| CN-104192817-A | Method for preparing mesoporous hydroxyapatite nanometer particle with high specific surface area by virtue of template method | HARBIN INST OF TECHNOLOGY | 2014-12-10 | — | — | CN | disclosed |
| CN-1142997-C | Process for producing D-pantoic acid and D-pantothenic acid or salts thereof | BASF | 2004-03-24 | — | — | CN | disclosed |
| EP-1142866-A9 | METHOD FOR PRODUCING CALCIUM PANTOTHENATE | Daiichi Fine Chemical Co., Ltd. (JP) | 2003-07-09 | — | — | EP | disclosed |
| US-6582940-B1 | Method for producing calcium pantothenate | DAIICHI FINE CHEMICAL CO., LTD. (JP) | 2003-06-24 | — | — | US | disclosed |
| EP-1142866-A1 | METHOD FOR PRODUCING CALCIUM PANTOTHENATE | Fuji Chemical Industries, Ltd. (JP) | 2001-10-10 | — | — | EP | disclosed |
| CN-1201491-A | Process for producing D-pantoic acid and D-pantothenic acid or salts thereof | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1998-12-09 | — | — | CN | disclosed |